Eptinezumab (Anti-CALCA / CGRP)
Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitoninĀ gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2790 |
Sku # | A2790-1mg*5 |
Pricing | 1mg*5, $970.00 |